Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XEN-D0103 in paroxysmal atrial fibrillation with pacemaker monitoring
2013-004456-38Phase 2Completed
- Sponsor
- Xention Ltd.
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of S066913 in Atrial fibrillation (AFib), sponsored by Xention Ltd. Primary endpoint: AF burden. Started Nov 2013; status: completed.
02
Drugs
S066913
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2013-004456-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004456-38.